No Association between the Response to the Addition of an Atypical Antipsychotic Drug to an SSRI or SNRI and the BDNF (Val66Met) Polymorphism in Refractory Major Depressive Disorder in Japanese Patients

OBJECTIVE: This study examined the association between the brain-derived neurotrophic factor (BDNF) (Val66Met) polymorphism and the response to the addition of an atypical antipsychotic drug to a selective serotonin reuptake inhibitor (SSRI) or serotonin-norepinephrine reuptake inhibitor (SNRI) in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshimura, Reiji, Kishi, Taro, Hori, Hikaru, Ikenouchi-Sugita, Atsuko, Umene-Nakano, Wakako, Katsuki, Asuka, Hayashi, Kenji, Iwata, Nakao, Nakamura, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569156/
https://www.ncbi.nlm.nih.gov/pubmed/23429762
http://dx.doi.org/10.9758/cpn.2012.10.1.49

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569156/
https://www.ncbi.nlm.nih.gov/pubmed/23429762
http://dx.doi.org/10.9758/cpn.2012.10.1.49

Ejemplares similares